MaxCyte
MXCT
123 hedge funds and large institutions have $78.1M invested in MaxCyte in 2026 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 28 reducing their positions, and 33 closing their positions.
82% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 28
70% more capital invested
Capital invested by funds: $45.9M → $78.1M (+$32.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.91% less ownership
Funds ownership: 61.01% → 59.1% (-1.9%)
6% less funds holding
Funds holding: 131 → 123 (-8)
18% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 33
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $123K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.54M |
| 2 |
RC
RBF Capital
San Francisco,
California
|
+$1.32M |
| 3 |
Millennium Management
New York
|
+$1.16M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$913K |
| 5 |
Two Sigma Investments
New York
|
+$852K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$5.72M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.67M |
| 3 |
LM
Luminus Management
Houston,
Texas
|
-$1.09M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.03M |
| 5 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
|
-$627K |
MXCT Hedge Fund Activity: Q2 2026 in Review
123 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2026, worth a combined $78.1M — up 70% from $45.9M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of MXCT and 27 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 51 added.
The largest buyer was Jane Street, adding an estimated $1.54M. The largest seller was BlackRock, cutting an estimated $5.72M.
- 123 institutional investors held MaxCyte (MXCT) as of Q2 2026, down from 131 in Q1 2026.
- Funds reported $78.1M of MaxCyte stock for Q2 2026, up 70% quarter-over-quarter.
- 27 funds opened new MaxCyte positions in Q2 2026 and 33 closed out, a net change of -6 holders.
- The largest MaxCyte buyer in Q2 2026 was Jane Street, an estimated $1.54M added.
- The largest MaxCyte seller in Q2 2026 was BlackRock, an estimated $5.72M sold.
Based on aggregated 13F filings for Q2 2026.